Literature DB >> 7870184

Beta-adrenoceptor-mediated facilitation of endogenous noradrenaline release from rat isolated trachea.

G Brunn1, I Wessler, G P Anderson, J Maclagan, K Racké.   

Abstract

Overflow of endogenous noradrenaline from rat isolated trachea was evoked by electrical field stimulation (3 Hz, 540 pulses) in the presence of yohimbine, desipramine and tyrosine. Isoprenaline 100 nmol/l increased the evoked overflow of noradrenaline by about 65%. This effect was antagonized by propranolol (100 nmol/l) and the beta 2-selective adrenoceptor antagonist ICI 118,551 (100 nmol/l), but not by the beta 1-selective adrenoceptor antagonist CGP 20712 A (100 nmol/l). The beta 2-selective adrenoceptor agonist formoterol (1-100 nmol/l) also facilitated the evoked overflow of noradrenaline, but maximally by only about 25% at 10 nmol/l, i.e. formoterol behaved as a partial agonist at these facilitatory beta-adrenoceptor. This assumption is also supported by the observation that formoterol (10 nmol/l) acted as antagonist against isoprenaline (100 nmol/l). Mechanical removal of the mucosa resulted in a 30% decrease in tissue noradrenaline and a 55% reduction of the evoked overflow of noradrenaline. In mucosa-denuded preparations isoprenaline failed to facilitate noradrenaline overflow. In the presence of indomethacin (3 mumol/l) the evoked overflow of noradrenaline from mucosa containing preparations was increased by about 50%, but isoprenaline still further facilitated the evoked noradrenaline overflow by about 40%. In conclusion, the overflow of noradrenaline in the rat trachea is facilitated via beta 2-adrenoceptors, an effect which requires an intact airway mucosa.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7870184     DOI: 10.1007/bf00173014

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  Characterization of the prejunctional beta adrenoceptors in canine bronchial smooth muscle.

Authors:  L J Janssen; E E Daniel
Journal:  J Pharmacol Exp Ther       Date:  1990-08       Impact factor: 4.030

Review 2.  Modulation of neurotransmitter release by presynaptic autoreceptors.

Authors:  K Starke; M Göthert; H Kilbinger
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

Review 3.  Innervation of airway smooth muscle: fine structure.

Authors:  G Gabella
Journal:  Annu Rev Physiol       Date:  1987       Impact factor: 19.318

4.  Norepinephrine release from the lung by sympathetic nerve stimulation inhibition by vagus and methacholine.

Authors:  A A Mathé; E Y Tong; P W Tisher
Journal:  Life Sci       Date:  1977-04-15       Impact factor: 5.037

5.  Subendothelial beta 2-adrenoceptors in the rat vena cava: facilitation of noradrenaline release via local stimulation of angiotensin II synthesis.

Authors:  M Göthert; P Kollecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

6.  Epithelium-derived inhibition of [3H]acetylcholine release from the isolated guinea-pig trachea.

Authors:  I Wessler; D Hellwig; K Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

7.  Evidence for the involvement of prostaglandins in modulation of acetylcholine release from canine bronchial tissue.

Authors:  I A Deckers; M Rampart; H Bult; A G Herman
Journal:  Eur J Pharmacol       Date:  1989-08-29       Impact factor: 4.432

Review 8.  Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator.

Authors:  G P Anderson
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

Review 9.  Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors.

Authors:  H Majewski
Journal:  J Auton Pharmacol       Date:  1983-03

Review 10.  Presynaptic beta-adrenoceptors.

Authors:  Y Misu; T Kubo
Journal:  Med Res Rev       Date:  1986 Apr-Jun       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.